Thus, heparanase is locally produced and degrades intra-β-cell HS, resulting in a decrease in overall islet β-cell HS and an increase in β-cell death and leading to a deficiency in insulin production capacity and the development of T1DM [136,137] (Figure 1). This evidence concerns the gene INS and type 1 diabetes mellitus.